Fig. 2From: Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failureKaplan–Meier analysis of post-failure survival in 407 patients with locoregional failure stratified by early (ELRF) and late locoregional failure (ELRF) (A); 511 patients with distant failure stratified by early (EDF) and late distant failure (EDF) (B)Back to article page